Purchase Order HHSN272201400348P
- Not listed
- This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,950 firm-fixed-price purchase order to Miltenyi Biotec, Inc. for maintenance services. The order was placed on December 5, 2014 with a completion date of December 14, 2015. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. This order is not associated with a set-aside program. Additionally, Miltenyi Biotec holds a...
- This is a $14,647 firm fixed-price purchase order awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID) for the delivery of a GentleMACS tissue homogenizer and associated supplies. The award is not associated with a set-aside. Miltenyi Biotec is an experienced federal contractor, having received numerous awards from agencies such as the NIH, VA, and DoD to provide specialized laboratory equipment, reagents, and...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of an AUTOMACS Pro Separator Instrument. The $36,906.00 contract has an ultimate completion date of August 8, 2013. Miltenyi Biotec has extensive experience as a prime contractor for the NIH, Department of Veterans Affairs, and other federal agencies,...
- This federal contract award is for a renewal maintenance agreement on a MACSQuant analyzer instrument, provided by Miltenyi Biotec, Inc. to the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The firm-fixed-price purchase order has a ceiling value of $22,224.00 and an ultimate completion date of March 2, 2023. Miltenyi Biotec is a global biotechnology company that regularly provides specialized laboratory equipment, reagents, and...
- This federal contract award to Miltenyi Biotec, Inc. is a $5,400 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is not set aside and has an ultimate completion date of May 15, 2013. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for one-time planned maintenance on an AUTOMACS Pro cell separator. The $4,194 contract has a completion date of March 31, 2018 and was awarded on January 29, 2018 without any set-aside designation. Miltenyi Biotec is an experienced federal contractor, providing...
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017. Miltenyi Biotec is a well-established federal contractor,...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to Miltenyi Biotec, Inc., a global biotechnology company, for the provision of two AUTOMACS Pro Separators. The $12,598.00 firm fixed-price purchase order contract has a completion date of December 14, 2018. Miltenyi Biotec specializes in scientific instruments, cell separation technology, and services supporting cell and gene...
This is a firm fixed price purchase order award to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID) for one-time planned maintenance on an Automacs Separator instrument. The award ceiling is $3,425.00 and covers the period from March 7, 2014 to December 31, 2014. Miltenyi Biotec is an experienced federal contractor, having received awards from various agencies including NIH, VA, FDA, DoD, CDC, and USDA. The company provides specialized scientific instruments, reagents, and services in support of biomedical research, cell therapy development, and clinical translation. This award does not use a set-aside designation. Additionally, Miltenyi Biotec holds a $2.3 million single-award indefinite delivery contract (IDC) with the NIH Clinical Center, awarded in June 2023. This IDC provides for the supply of proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027, in support of the NIH's cell processing and manufacturing capabilities for investigational cell therapy products used in clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 3/7/14 |